FTC reiterates pay-for-delay stance in amicus brief


The Federal Trade Commission urged a federal appeals court to reverse a lower court ruling in a reverse-payment settlement case. The ruling stated that an alleged non-cash payment between pharmaceutical companies to delay the market entry of a generic drug doesn’t violate antitrust laws because it was a non-cash payment.